Role of Inflammatory Markers in Sepsis

Role of Inflammatory Markers Measured Using Flow Cytometry in the Diagnosis and Prognosis of Sepsis in Surgical Cancer Patients

A diagnostic and prognostic study, in which the expression of CD64 in activated neutrophils and CD64 and IL17A regulatory T cells in patients with sepsis will be evaluated as a probable marker for sepsis as a primary objective

Inclusion Criteria:

• Cancer patients admitted to the surgical ICU following cancer related surgeries and diagnosed with sepsis

Exclusion Criteria:

• Refusal of patient or patient guardian to participate.
• Intraoperative massive blood loss and massive blood transfusion
• Patients with impaired preoperative kidney or liver function tests